Ignite Creation Date:
2024-05-06 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04723550
Status:
UNKNOWN
Last Update Posted:
2021-01-26
First Post:
2021-01-21
Brief Title:
COVID-19 Lockdown Related Telemedicine for Type 2 Diabetes
Sponsor:
Wenwen Yin
Organization:
Xuzhou No1 Peoples Hospital
Study Overview
Official Title:
Impact of Telemedicine on Young and Middle-aged Obese Patients With Type 2 Diabetes Mellitus During COVID-19 Pandemic
Status:
UNKNOWN
Status Verified Date:
2021-01
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
At present in order to cope with the global pandemic of the COVID-19 virus governments have introduced corresponding measures COVID-19 lockdown is one of the most important measures However lockdown makes the management of chronic diseases such as type 2 diabetes more difficult and telemedicine may be one of the solutions We hope to explore the effect of telemedicine on blood glucose control and other prognostic indicators of young and middle-aged obese patients with type 2 diabetes who will experience isolation control
Detailed Description:
We recruit patients with type 2 diabetes who need to be isolated due to the COVID-19 epidemic Our study will include young and middle-aged obese patients The lockdown period is 21 days The patients will be randomly divided into two groups with a total follow-up time of 6 months One group is the telemedicine intervention group and the other group is the routine follow-up control group The intervention group used the hospital telemedicine management system to upload blood glucose values fasting and 2h after three meals food intake of three meals and exercise volume Data collection frequency first three months 4 timesweek 4-6 Month 2 timesweekDoctors will collect data from hospital telemedicine management system to guide patients on diets exercise and medication adjustments The control group will be followed up by telephoneoutpatient clinic every 1 week only telephone follow-up will be conducted during the lockdown period Then doctors will collect their blood glucose valuesfasting and 2h after three meals Based on the data collected The doctors will provide lifestyle guidance to the patients on the telephone or face to face The clinical data of the two groups of patients will be collected at baseline 22 days 3 months and 6 months respectively HbA1c fasting blood glucoseFBG blood glucose 2 hours after breakfast blood pressure Body Mass IndexBMI waist-to-hip ratio total cholesterolTC triglycerideTG high-density lipoprotein cholesterolHDL-C low-density lipoprotein cholesterolLDL-C Blood Urea NitrogenBUN serum creatinineScr e-GFR Self-rating Depression Scale frequency of hypoglycemiaand Cost effectiveness The clinical data will be statistically analyzed
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None